QGEN

QGEN R&D Expenses

$194.67MTTM · USD

Period ending:

QGEN FY R&D ExpensesUSD
QGEN FY R&D Expenses1995-12-31: $4.40M1996-12-31: $6.50M1997-12-31: $8.30M1998-12-31: $12.80M1999-12-31: $16.27M2000-12-31: $22.21M2001-12-31: $26.77M2002-12-31: $28.18M2003-12-31: $31.79M2004-12-31: $34.16M2005-12-31: $39.10M2006-12-31: $41.56M2007-12-31: $64.94M2008-12-31: $97.33M2009-12-31: $107.90M2010-12-31: $126.04M2011-12-31: $130.64M2012-12-31: $122.48M2013-12-31: $146.07M2014-12-31: $163.63M2015-12-31: $147.18M2016-12-31: $176.14M2017-12-31: $154.08M2018-12-31: $161.85M2019-12-31: $157.45M2020-12-31: $149.07M2021-12-31: $189.96M2022-12-31: $189.86M2023-12-31: $198.51M2024-12-31: $193.49M2025-12-31: $187.52M$198.51M$0.00
1995-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

QGEN r&d expenses history

Research and development spending. The available annual fiscal periods series contains 31 observations from Dec 31, 1995 to Dec 31, 2025.

Qiagen N.V. Common Shares R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
187,516,000
193,494,000
198,511,000
189,859,000
189,964,000
149,072,000
157,448,000
161,852,000
154,084,000
176,135,000
147,180,000
163,627,000
146,070,000
122,476,000
130,636,000
126,040,000
107,900,000
97,331,000
64,935,000
41,560,000
39,100,000
34,159,000
31,789,000
28,177,000
26,769,000
22,212,000
16,271,000
12,800,000
8,300,000
6,500,000
4,400,000

Compare r&d expenses

All QGEN financial metrics · QGEN stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.